Premium
Type 2 Diabetes and HbA1c Predict All‐Cause Post‐Metabolic and Bariatric Surgery Hospital Readmission
Author(s) -
MoralesMarroquin Elisa,
Xie Luyu,
Meneghini Luigi,
CruzMuñoz Nestor,
Almandoz Jaime P.,
Mathew Sunil M.,
Schneider Benjamin E.,
Messiah Sarah E.
Publication year - 2021
Publication title -
obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.438
H-Index - 199
eISSN - 1930-739X
pISSN - 1930-7381
DOI - 10.1002/oby.23044
Subject(s) - medicine , type 2 diabetes , glycemic , prediabetes , diabetes mellitus , cohort , hemoglobin , retrospective cohort study , weight loss , surgery , emergency medicine , obesity , endocrinology
Objective The main goal of this analysis was to determine whether type 2 diabetes and hemoglobin A1c (HbA1c) predict all‐cause 30‐day hospital readmission after metabolic and bariatric surgery (MBS). It was hypothesized that a diagnosis of type 2 diabetes or high HbA1c values would predict all‐cause hospital readmission rates post MBS. Methods A retrospective analysis from the 2015‐2018 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) cohort was completed ( N = 744,776); 30,972 participants were readmitted during the 30 days post MBS. Results Mean age of the MBSAQIP sample was 45.1 (11.5) years, and the majority were female (80.7%) and non‐Hispanic White (59.4%). The all‐cause hospital readmission rate was 4.2% and increased by 10% in those with uncontrolled type 2 diabetes (HbA1c > 7.5% [> 58 mmol/mol]); after adjustment, diabetes was not associated with increased readmission. Uncontrolled type 2 diabetes, type 2 diabetes, and prediabetes resulted in less weight loss 30 days post MBS. Conclusions These results based on a national MBS cohort showed that uncontrolled type 2 diabetes is associated with a greater likelihood of all‐cause hospital readmission and reduced weight loss 30 days post MBS. Both type 2 diabetes and prediabetes were also associated with decreased weight loss 30 days post MBS. These findings highlight the need to classify and optimize glycemic control prior to MBS.